A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial conducted in the first half of 2021 and co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian. The trial, described in a […]
Antibody
New coronavirus variants made monoclonal antibody drugs ineffective
No more monoclonal antibody treatments for Covid are available in the U.S.: The Food and Drug Administration on Wednesday rescinded its authorization of bebtelovimab, a drug previously given to patients who faced a high risk of severe disease. Over the last two years, the FDA authorized six monoclonal antibody treatments […]
FDA OKs emergency use of antibody drug Trump received | Nation
U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month. The Food and Drug Administration authorized use of the Regeneron Pharmaceuticals Inc. drug to […]
Trump officials promise fair distribution of new covid-19 antibody drug, but limited supply and logistical problems loom
The federal government Monday granted emergency use authorization for the drug, seen as a powerful tool that could save people from developing the worst symptoms of covid-19 until a vaccine against the novel coronavirus is widely available. The federal government has more than 80,000 doses ready for allocation and distribution […]
Lilly Stops Antibody Trial in Hospitalized COVID-19 Patients
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Eli Lilly announced it will halt its ACTIV-3 trial evaluating the antibody bamlanivimab in combination with remdesivir for people hospitalized with COVID-19, after new evidence regarding efficacy emerged. The new data from the National Institutes of […]